283 related articles for article (PubMed ID: 24958899)
1. Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.
Peng X; Keitany GJ; Vignali M; Chen L; Gibson C; Choi K; Huang F; Wang R
J Immunol; 2014 Aug; 193(3):1268-77. PubMed ID: 24958899
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.
Belnoue E; Voza T; Costa FT; Grüner AC; Mauduit M; Rosa DS; Depinay N; Kayibanda M; Vigário AM; Mazier D; Snounou G; Sinnis P; Rénia L
J Immunol; 2008 Dec; 181(12):8552-8. PubMed ID: 19050274
[TBL] [Abstract][Full Text] [Related]
3. CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.
Doll KL; Butler NS; Harty JT
Vaccine; 2014 Jan; 32(4):483-91. PubMed ID: 24321740
[TBL] [Abstract][Full Text] [Related]
4. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment.
Belnoue E; Costa FT; Frankenberg T; Vigário AM; Voza T; Leroy N; Rodrigues MM; Landau I; Snounou G; Rénia L
J Immunol; 2004 Feb; 172(4):2487-95. PubMed ID: 14764721
[TBL] [Abstract][Full Text] [Related]
5. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites.
Mauduit M; Tewari R; Depinay N; Kayibanda M; Lallemand E; Chavatte JM; Snounou G; Rénia L; Grüner AC
Infect Immun; 2010 May; 78(5):2182-8. PubMed ID: 20194600
[TBL] [Abstract][Full Text] [Related]
6. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
7. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.
Keitany GJ; Sack B; Smithers H; Chen L; Jang IK; Sebastian L; Gupta M; Sather DN; Vignali M; Vaughan AM; Kappe SH; Wang R
Infect Immun; 2014 Dec; 82(12):5143-53. PubMed ID: 25267837
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites.
Minkah NK; Wilder BK; Sheikh AA; Martinson T; Wegmair L; Vaughan AM; Kappe SHI
Nat Commun; 2019 Sep; 10(1):3950. PubMed ID: 31477704
[TBL] [Abstract][Full Text] [Related]
9. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development.
Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R
Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
[TBL] [Abstract][Full Text] [Related]
11. Vaccination using normal live sporozoites under drug treatment.
Rénia L; Grüner AC; Mauduit M; Snounou G
Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
[TBL] [Abstract][Full Text] [Related]
12. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
13. Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity.
Voza T; Kebaier C; Vanderberg JP
Malar J; 2010 Dec; 9():362. PubMed ID: 21159170
[TBL] [Abstract][Full Text] [Related]
14. Repetitive live sporozoites inoculation under arteether chemoprophylaxis confers protection against subsequent sporozoite challenge in rodent malaria model.
Bhardwaj J; Siddiqui AJ; Goyal M; Prakash K; Soni A; Puri SK
Acta Trop; 2016 Jun; 158():130-138. PubMed ID: 26925772
[TBL] [Abstract][Full Text] [Related]
15. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
17. The Toll-Like Receptor 2 agonist PEG-Pam
Ernest M; Hunja C; Arakura Y; Haraga Y; Abkallo HM; Zeng W; Jackson DC; Chua B; Culleton R
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):451-458. PubMed ID: 30396012
[TBL] [Abstract][Full Text] [Related]
18. Humanized DRAGA mice immunized with Plasmodium falciparum sporozoites and chloroquine elicit protective pre-erythrocytic immunity.
Majji S; Wijayalath W; Shashikumar S; Brumeanu TD; Casares S
Malar J; 2018 Mar; 17(1):114. PubMed ID: 29540197
[TBL] [Abstract][Full Text] [Related]
19. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.
Purcell LA; Wong KA; Yanow SK; Lee M; Spithill TW; Rodriguez A
Vaccine; 2008 Sep; 26(38):4880-4. PubMed ID: 18672017
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
Charoenvit Y; Majam VF; Corradin G; Sacci JB; Wang R; Doolan DL; Jones TR; Abot E; Patarroyo ME; Guzman F; Hoffman SL
Infect Immun; 1999 Nov; 67(11):5604-14. PubMed ID: 10531206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
